How an antibiotic acts as an antiviral, hitting the COVID-19 virus with a three-pronged attack
New research published in the International Journal of Computational Biology and Drug Design describes a novel lipopeptide antibiotic that can inhibit the replication of the SARS-CoV-2 virus, which causes COVID-19. The compound, ...